Abstract:Background: Liver fibrosis is characterized by extensive deposition of extracellular matrix (ECM) components in the liver. RCAN1 (regulator of calcineurin 1), an endogenous inhibitor of calcineurin (CaN), is required for ECM synthesis during hypertrophy of various organs. However, the functional role of RCAN1 in liver fibrogenesis has not yet been addressed. Methods: We induced experimental liver fibrosis in mice by intraperitoneal injection of 10 % CCl4 twice a week. To investigate the functional role of RCAN1.4 in the progression of liver fibrosis, we specifically over-expressed RCAN1.4 in mice liver using rAAV8-packaged RCAN1.4 over-expression plasmid. Following the establishment of the fibrotic mouse model, primary hepatic stellate cells were isolated. Subsequently, we evaluated the effect of RCAN1.4 on hepatic fibrogenesis, hepatic stellate cell activation, and cell survival. The biological role and signaling events for RCAN1 were analyzed by protein-protein interaction (PPI) network. Bisulfite sequencing PCR (BSP) was used to predict the methylated CpG islands in the RCAN1.4 gene promoter. We used the chromatin immunoprecipitation (ChIP assay) to investigate DNA methyltransferases which induced decreased expression of RCAN1.4 in liver fibrosis. Results: Two isoforms of RCAN1 protein were expressed in CCl4-induced liver fibrosis mouse model and HSC-T6 cells cultured with transforming growth factor-beta 1 (TGF-beta 1). RCAN1 isoform 4 (RCAN1.4) was selectively down-regulated in vivo and in vitro. The BSP analysis indicated the presence of two methylated sites in RCAN1.4 promoter and the downregulated RCAN1.4 expression levels could be restored by 5-aza-2'-deoxycytidine (5-azadC) and DNMTs-RNAi transfection in vitro. ChIP assay was used to demonstrate that the decreased RCAN1.4 expression was associated with DNMT1 and DNMT3b. Furthermore, we established a CCl4-induced liver fibrosis mouse model by injecting the recombinant adeno-associated virus-packaged RCAN1.4 (rAAV8-RCAN1.4) over-expression plasmid through the tail vein. Liver- specific-over-expression of RAN1.4 led to liver function recovery and alleviated ECM deposition. The key protein (a member of the NFAT family of proteins) identified on PPI network data was analyzed in vivo and in vitro. Our results demonstrated that RCAN1.4 over-expression alleviates, whereas its knockdown exacerbates, TGF-beta 1-induced liver fibrosis in vitro in a CaN/NFAT3 signaling-dependent manner. Conclusions: RCAN1.4 could alleviate liver fibrosis through inhibition of CaN/NFAT3 signaling, and the anti-fibrosis function of RCAN1.4 could be blocked by DNA methylation mediated by DNMT1 and DNMT3b. Thus, RCAN1.4 may serve as a potential therapeutic target in the treatment of liver fibrosis.

RCAN1.4 mediates high glucose-induced matrix production by stimulating mitochondrial fission in mesangial cells

High Glucose-induced Fibronectin Upregulation in Cultured Mesangial Cells Involves Caveolin-1-dependent RhoA-GTP Activation Via Src Kinase

The RCAN1.4-calcineurin/NFAT Signaling Pathway is Essential for Hypoxic Adaption of Intervertebral Discs

ROCK1 Induces Endothelial-to-Mesenchymal Transition in Glomeruli to Aggravate Albuminuria in Diabetic Nephropathy

RCAN1.4 Attenuates Renal Fibrosis Through Inhibiting Calcineurin-Mediated Nuclear Translocation of NFAT2

Regulators of Calcineurin 1 Deficiency Attenuates Tubulointerstitial Fibrosis Through Improving Mitochondrial Fitness.

Regulator of calcineurin 1 deletion attenuates mitochondrial dysfunction and apoptosis in acute kidney injury through JNK/Mff signaling pathway

Akt and RhoA Activation in Response to High Glucose Require Caveolin-1 Phosphorylation in Mesangial Cells

Epigenetic regulation of RCAN1 expression in kidney disease and its role in podocyte injury

RhoA/Rho-kinase Contribute to the Pathogenesis of Diabetic Renal Disease.

CK2α Promotes Advanced Glycation End Products-Induced Expressions of Fibronectin and Intercellular Adhesion Molecule-1 Via Activating MRTF-A in Glomerular Mesangial Cells.

The Regulator of Calcineurin 1 Increases Adenine Nucleotide Translocator 1 and Leads to Mitochondrial Dysfunctions.

Obesity-Induced Regulator of Calcineurin 1 Overexpression Leads to Β-Cell Failure Through Mitophagy Pathway Inhibition

Elevated Transcriptional Co-Activator P102 Mediates Angiotensin II Type 1 Receptor Up-Regulation and Extracellular Matrix Overproduction in the High Glucose-Treated Rat Glomerular Mesangial Cells and Isolated Glomeruli.

Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling.

MAPK1 Mediates MAM Disruption and Mitochondrial Dysfunction in Diabetic Kidney Disease Via the Mechanism

AKAP1 Mediates High Glucose-Induced Mitochondrial Fission Through the Phosphorylation of Drp1 in Podocytes

RCAN1.4 Acts As a Suppressor of Cancer Progression and Sunitinib Resistance in Clear Cell Renal Cell Carcinoma

Modulators of Alpha-2 Macroglobulin Upregulation by High Glucose in Glomerular Mesangial Cells

Regulator of Calcineurin 1 Gene Isoform 4 in Pancreatic Ductal Adenocarcinoma Regulates the Progression of Tumor Cells

MAPK1 Mediates MAM Disruption and Mitochondrial Dysfunction in Diabetic Kidney Disease via the PACS-2-Dependent Mechanism